Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.
about
How hyperglycemia promotes atherosclerosis: molecular mechanisms.The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded.Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyHow exercise may amend metabolic disturbances in diabetic cardiomyopathyCoronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalitiesProtein kinase C mechanisms that contribute to cardiac remodellingMolecular and Cellular Mechanisms of Cardiovascular Disorders in DiabetesInvolvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cellsN-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic ratsIdentification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissueOxidative stress and diabetic complicationsPresence and Risk Factors for Glaucoma in Patients with Diabetes.Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.Anti-angiogenic therapy of proliferative diabetic retinopathy.Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation.Brief rapid pacing depresses contractile function via Ca(2+)/PKC-dependent signaling in cat ventricular myocytes.Pharmacologic therapy for diabetic retinopathy.Diabetic macular edema: classification, medical and laser therapy.Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation.Current and future pharmacological intervention for diabetic retinopathy.Pharmacologic therapies for diabetic retinopathy and diabetic macular edemaMolecular mechanisms of diabetic vascular complicationsHigh-glucose levels and elastin degradation products accelerate osteogenesis in vascular smooth muscle cellsObesity-associated Gingival Vascular Inflammation and Insulin Resistance.Wounding the cornea to learn how it heals.Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathwaysActivation of protein kinase C isoforms and its impact on diabetic complications.Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunctionEndothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetesProtein kinase C activation and its pharmacological inhibition in vascular disease.C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells.Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.Cell metabolism: an essential link between cell growth and apoptosisTherapeutic potential of PKC inhibitors in painful diabetic neuropathy.Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus.Protein kinase C and the development of diabetic vascular complications.The pathogenesis of diabetic retinopathy: old concepts and new questions.
P2860
Q24795988-990CC641-543D-43D9-A876-F892EBE3F3C7Q24811354-2CFB831E-792D-4214-8856-3F5D9A7A4F34Q26799594-432E0E23-2E06-43FE-9FB7-250BD57C23A8Q26863272-E8619E24-F4AD-440F-A476-A85EAACDF7C4Q26866204-CF325724-811D-4F6F-B256-C0E7E74B0D28Q28075729-532F2D92-38C4-4509-9DC3-27BCB923EEB5Q28395675-E8DE3FEC-EE57-46DE-ACFA-ECB42FC55CB3Q28566691-6F80531E-3959-4B79-9F87-A28AE193FC64Q28573358-EEE43DA8-12B5-424B-BB4F-B5A2B650B666Q28577919-72D4C964-FFD1-4E32-9024-09FAC35ADB08Q29615423-203238A5-E790-483C-AF50-696A73EA431AQ30244246-EBA6E0EE-B4FA-4A8F-B142-6626B7B72C88Q30631779-C3681653-F569-4426-B9AC-1CA0F0C91D72Q30666418-56DCB714-1564-4903-BF34-30F37051227DQ31442067-02F7960A-374E-4E4A-8590-C46DD69FA915Q31722171-DAD446BA-351F-4812-80FA-E87A93692C54Q33194915-EDC23BF2-1965-4A12-9BA6-57829DAED560Q33208471-07DE5446-E67F-481C-A324-287A7CC533E0Q33214227-F32F6FE8-B66E-44B2-8B82-CB33045F5FCEQ33216425-39DF51A0-BF41-44D1-BD17-ACFA13FB8B5DQ33492340-6DEF73AD-3BCA-4DA8-8AB6-1A78258016ECQ33558421-1C61059C-2E35-49A8-9007-3FEA2B996F7FQ33598401-8647FAE6-DEF5-425C-BCD4-806228EEBFEDQ33621746-0629E5EF-9842-425D-8DEC-E2CE1CA2AAD8Q33811160-479D71F8-5311-4F6E-965C-96666EB2438DQ33834722-784EA860-83DA-463C-8E29-34559D425D99Q33881442-AC9C4127-089A-41EE-AB7B-7F2C3EC2C076Q33899819-0C3216E5-3095-4502-9E62-6E5D403E0F08Q33901576-8DD0CE84-E0C9-4E1E-ABF8-3775C15038D3Q33917811-BF086AA6-2213-458C-A2D0-8F95805813E8Q34031989-0AA86F5B-7528-4CE8-A0A1-E23C9C203B63Q34097328-B434AAA1-ED71-4F6D-8652-72A1B92891F1Q34097615-80E3E270-AB0C-435B-B316-0B30DA2FA205Q34224574-C3B2E029-5CC5-4366-8147-21FB57CB0A22Q34372508-90196BE6-C3BA-4C75-AA81-F62E4E1E87A3Q34440592-E321D667-0F61-41A7-9C52-249D2E3774B2Q34481699-309268B8-0396-451B-87C5-C5C2B51D0138Q34496436-8C44CB39-4DB2-45F6-9DFF-8091FD05EAB2Q34570516-9710D45C-2AEA-4E17-A76A-3E0121A4B7A5Q34658478-4489F88B-FB1C-48C5-AFF4-666B95A2F1E8
P2860
Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Preferential elevation of prot ...... by islet cell transplantation.
@en
Preferential elevation of prot ...... by islet cell transplantation.
@nl
type
label
Preferential elevation of prot ...... by islet cell transplantation.
@en
Preferential elevation of prot ...... by islet cell transplantation.
@nl
prefLabel
Preferential elevation of prot ...... by islet cell transplantation.
@en
Preferential elevation of prot ...... by islet cell transplantation.
@nl
P2093
P2860
P356
P1476
Preferential elevation of prot ...... by islet cell transplantation.
@en
P2093
P2860
P304
11059-11063
P356
10.1073/PNAS.89.22.11059
P407
P577
1992-11-01T00:00:00Z